| Literature DB >> 32642280 |
Shuiping Liu1,2, Lvjia Zhuo1,2, Jianjun Wang1, Qin Zhang1,2, Qiujie Li1,2, Guohua Li1,2, Lili Yan1,2, Ting Jin1,2, Ting Pan1,2, Xinbing Sui1,2, Qun Lv1, Tian Xie1,2.
Abstract
N6-methyladenosine (m6A) is the most common internal modification of mRNAs in higher eukaryotic. This process is performed by methyltransferase. Methyltransferase-like 3 (METTL3) is the best known m6A methyltransferase that functions in the reversible epi-transcriptome modulation of m6A modification. Besides acting as a m6A methyltransferase, METTL3 also regulates mRNA translation and other biological processes. In recent years, studies have identified numerous roles and molecular mechanisms associated with METTL3 in multiple biological processes. However, these findings have not been summarized. In this review, we have systematically summarized the most recent important roles of METTL3 in various biological processes, including cell cycle progression, cell proliferation, cell apoptosis, cell migration and invasion, cell differentiation and inflammatory response. In addition, we discuss the prospect of using a METTL3 as a new diagnostic biomarker and therapeutic target for human cancers. AJCREntities:
Keywords: METTL3; biological process; cancer therapy; diagnostic biomarker; m6A modification
Year: 2020 PMID: 32642280 PMCID: PMC7339281
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166